UBQLN4 and malignant mesothelioma: The finding that UBQLN4 is high expressed in mesothelioma and knockdown of UBQLN4 enhances the sensitivity to DNA damage drugs may provide a new molecular strategy for the treatment of malignant mesothelioma.